REPPORT
Key information
Title:
REPPORT: REcurrent Patellar dislocation: Personalised therapy or OpeRative Treatment?
Chief Investigator: Professor Andrew Metcalfe & Professor Toby Smith
Sponsor: 天美传媒
Funder: NIHR Health Technology Assessment Programme
Registration Number: ISRCTN 17972668
Summary:
Recurrent dislocation and instability of the patella (knee cap) can be a profoundly disabling condition. Recurrent dislocations may persist for many decades causing pain, cartilage, and soft tissue injury which can lead to long-term disability. The REPPORT trial is looking to compare a physiotherapy intervention (PKT: Personalised Knee Therapy) versus surgery. Both physiotherapy and surgery are both options for treating repeated kneecap dislocations and available in the NHS, however it is not know if one is better than the other. The REPPORT trial will offer 50% of randomised patients PKT and 50% Surgery and will compare patient reported results to see if which treatment plan has the best patient outcomes.
Sample size:
276 (1:1 Ratio)
Primary outcome:
Duration:
Students are required to complete a formative assessment at the end of each block. Students are given the right to sit summative assessments based on completion of formative assessments, engagement with the programme and attendance. Summative assessments are at the end of year one, end of year two and in the final year.
Due to the pressures on car parking capacity on campus it is not possible to provide dedicated parking for students. Students can access Pay-and-Display spaces and Pay-on-Foot car parks..
Yes, first year students are normally placed in Tocil with other Postgraduate students. There is also off campus Warwick Accommodation available.
This study is funded by the NIHR Health Technology Assessment (HTA) Programme (NIHR134398). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.
Contact Us
Chief Investigators: Professor Andrew Metcalfe and Professor Toby Smith
Trial Manager: Manjit Aujla